CGTN: How China strengthens vaccine cooperation to battle COVID-19
BEIJING, Dec. 15, 2022 /PRNewswire/ -- Since the outbreak of COVID-19, the world has raced against time, battling the pandemic as it wreaked havoc across the globe. Developing safe and effective vaccines is one of the most crucial steps in the fight against the virus. For the last nearly three years, China has made strides in its COVID-19 vaccine...
Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease
SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place in San Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will also be giving an oral presentation on new pre-clinical data for its LMNA cardiac gene therapy...
U.S. FDA Approves Clinical Trial Application for IASO Bio’s BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma
SHANGHAI and NANJING, China and SAN JOSE, Calif., Dec. 22, 2022 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products,, today announced that the Investigational New Drug (IND) application for its in-house developed BCMA CAR-T CT103A (equecabtagene autoleucel) has been...
Telix Reports Fourth Quarter 2022 Financial Results
MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- 18 January 2023. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 31 December 2022 (Q4 2022). All figures are in AUD$ unless otherwise stated1 and provided on an unaudited...
VISTA Eye Specialist to host Eye Health Carnival Nationwide in Malaysia
PETALING JAYA, Malaysia, Jan. 20, 2023 /PRNewswire/ -- In an effort to increase eye health awareness for Malaysians, particularly on the top 3 causes of preventable blindness, VISTA Eye Specialist is excited to announce the return of their Eye Health Carnival nationwide, happening mid-February, 2023 at 12 of its centers across Malaysia. Themed "Happy TuGather", this year's carnival is...
Lunit and Agfa HealthCare bring breast imaging AI solution to Dubai Academic Health Corporation (DAHC) Dubai Hospital
Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnostic and Screening program with Agfa HealthCare's RUBEE for AI framework and Lunit INSIGHT MMG algorithm The Breast AI Analysis Package is Lunit's first application with Agfa HealthCare since forming a strategic partnership in 2021 SEOUL, South Korea,...
Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio
Duoning obtained exclusive license from BioAces for its cell analysis portfolio Through the partnership, the two companies will advance the development and commercialization of cell counters worldwide SHANGHAI, Feb. 20, 2023 /PRNewswire/ -- Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") entered into a strategic partnership with BioAces Shanghai Life Science Co., Ltd. ("BioAces") to obtain the exclusive global...
AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL®, the Progressive Extended Depth-of-Focus IOL
SHANGHAI, March 3, 2023 /PRNewswire/ -- AffaMed Technologies ("AffaMed"), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of the first patient implantation in the Registrational Clinical Trial of its MINI WELL® progressive Extended Depth-of-Focus ("EDOF") IOL (MINI WELL®), which was conducted in the EYE & ENT Hospital of Fudan University in Shanghai,...
SiYi Intelligence Raises Nearly $15 Million in Series A Financing
SHANGHAI, March 6, 2023 /PRNewswire/ -- SiYi Intelligence, an intelligent rehabilitation solution provider, completed nearly 15 million US dollars in Series A financing. This round was led by Chengdu Bio-town Equity Investment Fund with participation from existing investor Tao Capital. The company plans to use the funding to accelerate the R&D of integration solutions for neurorehabilitation and build the digital...
Jacobio Pharma Announces 2022 Annual Results
BEIJING, SHANGHAI and BOSTON, March 22, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced its 2022 annual results. R&D investment was RMB530 million, showing an increase of 26% compared with 2021. The revenue was RMB95.7 million, which was generated from an out-licensing deal. Jacobio Pharma also announced its recent business progress and expected milestones. Dr. Wang...
